Renaissance Technologies - SOLENO THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,816
+541.7%
61,554
-6.8%
0.00%
Q2 2023$283
+72.6%
66,054
-13.7%
0.00%
Q1 2023$164
+65.7%
76,515
+53.8%
0.00%
Q4 2022$99
-99.9%
49,754
+10.7%
0.00%
Q3 2022$75,00044,9540.00%
Other shareholders
SOLENO THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Sassicaia Capital Advisers LLC 8,655$255,40912.02%
Vivo Capital, LLC 3,203,093$94,523,27410.36%
Fairmount Funds Management LLC 1,142,473$33,714,3784.06%
SILVERARC CAPITAL MANAGEMENT, LLC 370,000$10,918,7003.31%
COMMODORE CAPITAL LP 887,500$26,190,1253.06%
Perceptive Advisors 3,074,542$90,729,7343.03%
Carlyle Group Inc. 2,293,562$67,430,7232.92%
Ikarian Capital, LLC 536,720$15,838,6081.90%
Nantahala Capital Management 392,404$11,579,8420.99%
Frazier Life Sciences Management, L.P. 464,937$13,720,2910.91%
View complete list of SOLENO THERAPEUTICS INC shareholders